"This could be worth millions." Archangel said, looking at the information. "Provided the research is on the money." The files contained reports and documentation concerning new organic tissue implants that would end the need for immuno-suppressive drugs that caused almost as many problems for transplant patients as they solved. Skater didn’t understand it all, but the gist was that NuGene had discovered a means of over-writing the DNA in the patient and in vat-grown donor tissue to create a hybrid that allowed the coexistence of both systems.